FDA Clearance Tracker · P140018-S044
VenaSeal Closure System
Last checked: Nov 20, 2026Latest source record: May 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 20, 2025
Approved
Time to decision
279 days
Received Aug 14, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140018-S044
- Device name
- VenaSeal Closure System
- Applicant
- Medtronic Vascular, Inc.
- Applicant location
- Plymouth, MN
- Received
- Aug 14, 2024
- Decided
- May 20, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P140018
Device type
- Device type
- Agent, occluding, vascular, permanent (PJQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
an additional supplier of one of the raw materials of the VenaSeal adhesive
Source documents
Other decisions for Medtronic Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K202800 · Decided Nov 18, 2020 · 56 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
P200026 · Decided Oct 21, 2020 · 177 days after receipt
Device type: Stent, iliac vein (QAN) · Cardiology
P190008 · Decided Nov 21, 2019 · 232 days after receipt
Device type: Drug-coated peripheral transluminal angioplasty catheter (PRC) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.